Drug Topics Newsletter

To view this email as a web page, click here.

PHARMACISTS' REPORT

Morris & Dickson Settle For $22 Million for Failing to Report Suspicious Opioid Orders

The action by the U.S. Attorney's Office is the latest in legal and policy maneuvers aimed at ending the opioid epidemic.

Lenalidomide Approved by FDA for Follicular and Marginal Zone Lymphoma

This thalidomide analog is also indicated for multiple myeloma and myelodysplastic syndromes.

Your pharmacy of the future

As patient needs place greater demands on PCPs, pharmacy is changing — and it means opportunities for new lines of service. This eBook contains a detailed step-by-step you can use to ready your pharmacy for the future! Download it now.

Scientists Are One Step Closer to a Needleless Hepatitis Vaccine

Medical researchers and physicists are collaborating on oral vaccine research.

Pharmacogenomics and the Future of Pharmacy

Why it’s vital for pharmacists to learn about this emerging field.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.